Lawrence Marsh - AmerisourceBergen President

ABCDelisted Stock  USD 179.98  0.95  0.53%   

President

Mr. Lawrence C. Marsh, is Executive Vice President New Market Development, Chief Strategy Officer of the Company. He was Senior Vice President, New Market Development and Chief Strategy Officer from November 2012 to November 2014. Before joining the Company, Mr. Marsh was a Managing Director in Equity Research at Barclays Capital from 2008 to 2012. since 2014.
Age 54
Tenure 10 years
Phone610 727 7000
Webhttps://www.amerisourcebergen.com

AmerisourceBergen Management Efficiency

The company has Return on Asset of 0.027 % which means that on every $100 spent on assets, it made $0.027 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.3366 %, implying that it generated $2.3366 on every 100 dollars invested. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 5.7 B in debt. AmerisourceBergen has a current ratio of 0.89, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist AmerisourceBergen until it has trouble settling it off, either with new capital or with free cash flow. So, AmerisourceBergen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AmerisourceBergen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AmerisourceBergen to invest in growth at high rates of return. When we think about AmerisourceBergen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Anand JayapalanMicron Technology
N/A
Derek DickerMicron Technology
N/A
Joel PoppenMicron Technology
53
David WangAdvanced Micro Devices
N/A
Manoj KanskarNLIGHT Inc
N/A
Martin CotterAnalog Devices
59
Robert PeglarMicron Technology
N/A
Tim VitouBK Technologies
N/A
Rick HessAnalog Devices
61
Yusuf JamalAnalog Devices
40
William KellyBK Technologies
61
Scott DeBoerMicron Technology
58
Jeff VerHeulMicron Technology
N/A
Sumit SadanaMicron Technology
55
David ZinsnerMicron Technology
48
Prashanth MahendraRajahAnalog Devices
54
Darren GrasbyAdvanced Micro Devices
48
April ArnzenMicron Technology
46
Margaret SeifAnalog Devices
56
Joseph HassettAnalog Devices
66
Thomas WesselAnalog Devices
47
AmerisourceBergen Corporation sources and distributes pharmaceutical products. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Amerisourcebergen operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 000 people. AmerisourceBergen (ABC) is traded on New York Stock Exchange in USA and employs 46,000 people.

Management Performance

AmerisourceBergen Leadership Team

Elected by the shareholders, the AmerisourceBergen's board of directors comprises two types of representatives: AmerisourceBergen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AmerisourceBergen. The board's role is to monitor AmerisourceBergen's management team and ensure that shareholders' interests are well served. AmerisourceBergen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AmerisourceBergen's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Frary, Executive VP and President of AmerisourceBergen Speciality Group
PharmD Mauch, Ex COO
James Cleary, Executive Vice President and Presidentident - MWI Veterinary Supply
Lonie Haynes, Senior Vice President Chief Diversity and Inclusion Officer
Dale Danilewitz, Executive Vice President, Chief Information Officer
Bennett Murphy, Vice President Investor Relations
Peyton HowellKoren, Executive Vice President AmerisourceBergen Corporation, and President Global Sourcing & Manufacturer Relations
Mark Durcan, Independent Director
John Chou, Executive Vice President, Chief Legal Officer and Secretary
Barbara Brungess, Vice President Corporate & Investor Relations
Dennis Nally, Independent Director
Elizabeth Campbell, Senior Vice President and Deputy General Counsel
Silvana Battaglia, Chief Human Resource Officer, Executive Vice President
Leslie Donato, Executive Vice President and Chief Strategy Officer
Lazarus Krikorian, Senior Vice President Principal Accounting Officer, Corporate Controller
Lawrence Marsh, Executive Vice President - New Market Development, Chief Strategy Officer
Henry McGee, Independent Director
Michael Long, Independent Director
Steven Collis, CEO and President Director and Member of Executive Committee
Robert Mauch, Executive Vice President, Group President - Pharmaceutical Distribution & Strategic Global Sourcing
Keri Mattox, Vice President - Corporate & Investor Relations
Sun Park, Executive Vice President - Strategy and Development
Ornella Barra, Director
Richard Gochnauer, Independent Director
Tim Guttman, CFO and Executive VP
Peyton Howell, Senior Vice President and Presidentident - Global Sourcing and Manufacturer Relations
Lon Greenberg, Independent Director
Gina Clark, Executive Vice President, Chief Communications & Administration Officer
D Durcan, Independent Director
David Neu, Executive VP of Retail Strategy and President of Good Neighbor Pharmacy
Douglas Conant, Independent Director
Kathleen Hyle, Independent Director
Kathy Gaddes, Chief Human Resource Officer, Executive Vice President
Jane Henney, Lead Independent Director
Richard Gozon, Independent Chairman of the Board
June Barry, Senior Vice President - Human Resources

AmerisourceBergen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AmerisourceBergen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AmerisourceBergen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AmerisourceBergen's short interest history, or implied volatility extrapolated from AmerisourceBergen options trading.

Pair Trading with AmerisourceBergen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AmerisourceBergen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AmerisourceBergen will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to AmerisourceBergen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AmerisourceBergen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AmerisourceBergen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AmerisourceBergen to buy it.
The correlation of AmerisourceBergen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AmerisourceBergen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AmerisourceBergen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AmerisourceBergen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the AmerisourceBergen information on this page should be used as a complementary analysis to other AmerisourceBergen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in AmerisourceBergen Stock

If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities